|
43
|
204
|
5mpc3 |
26s proteasome in presence of befx (s4) |
|
41
|
195
|
5mp94 |
26s proteasome in presence of atp (s1) |
|
48
|
241
|
5mp9A |
26s proteasome in presence of atp (s1) |
|
69
|
243
|
5m2bF |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
43
|
226
|
5mpa2 |
26s proteasome in presence of atp (s2) |
|
45
|
222
|
5mpc6 |
26s proteasome in presence of befx (s4) |
|
48
|
222
|
5mp96 |
26s proteasome in presence of atp (s1) |
|
59
|
243
|
5mpbG |
26s proteasome in presence of amp-pnp (s3) |
|
44
|
196
|
5mpb1 |
26s proteasome in presence of amp-pnp (s3) |
|
48
|
195
|
5mpa4 |
26s proteasome in presence of atp (s2) |
|
52
|
242
|
5mp9E |
26s proteasome in presence of atp (s1) |
|
63
|
240
|
5mp9D |
26s proteasome in presence of atp (s1) |
|
60
|
195
|
5m2bJ |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
51
|
222
|
5mpa6 |
26s proteasome in presence of atp (s2) |
|
53
|
242
|
5mpcE |
26s proteasome in presence of befx (s4) |
|
51
|
212
|
5mpc5 |
26s proteasome in presence of befx (s4) |
|
49
|
233
|
5mpbF |
26s proteasome in presence of amp-pnp (s3) |
|
46
|
204
|
5mpa3 |
26s proteasome in presence of atp (s2) |
|
55
|
244
|
5mpbC |
26s proteasome in presence of amp-pnp (s3) |
|
49
|
229
|
5mpa7 |
26s proteasome in presence of atp (s2) |
|
40
|
234
|
5m32E |
Human 26s proteasome in complex with oprozomib |
|
53
|
242
|
5mpaE |
26s proteasome in presence of atp (s2) |
|
56
|
212
|
5mpb5 |
26s proteasome in presence of amp-pnp (s3) |
|
44
|
212
|
5mpa5 |
26s proteasome in presence of atp (s2) |
|
50
|
241
|
5mpaA |
26s proteasome in presence of atp (s2) |
|
50
|
229
|
5mpc7 |
26s proteasome in presence of befx (s4) |
|
62
|
241
|
5m2bG |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
45
|
232
|
5ln3E |
The human 26s proteasome at 6.8 ang. |
|
59
|
226
|
5l66H |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
53
|
216
|
5m32M |
Human 26s proteasome in complex with oprozomib |
|
55
|
204
|
5lezI |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
62
|
244
|
5lf1G |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
61
|
220
|
5lf7H |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
62
|
231
|
5l6aE |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
59
|
226
|
5l5uH |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
64
|
211
|
5l68K |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
65
|
211
|
5l67K |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
70
|
244
|
5l65B |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
44
|
230
|
5m32A |
Human 26s proteasome in complex with oprozomib |
|
59
|
226
|
5l65H |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
65
|
230
|
5lf3A |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
59
|
196
|
5l5zN |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
62
|
222
|
5lzpA |
Binding of the c-terminal gqyl motif of the bacterial proteasome activator bpa to the 20s proteasome |
|
70
|
244
|
5l6cB |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
69
|
230
|
5le5A |
Native human 20s proteasome at 1.8 angstrom |
|
69
|
244
|
5l5zB |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
65
|
244
|
5lf4G |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
64
|
241
|
5l5oG |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
58
|
196
|
5l6cN |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
70
|
240
|
5l5eC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
